SlideShare a Scribd company logo
PREPARED BY
TIRTHARAJ ACHARYA
H.A
NOW THUMKI HEALTH POST
tirtharaja76@gmail.com
1
HYPERTENSION
Definition of Hypertension
Dorland’s Medical Dictionary
 “Persistently high arterial blood pressure”
Diastolic Hypertension
 Elevated diastolic blood pressure with a normal systolic
pressure
Essential Hypertension
 Elevated blood pressure “having no obvious external cause,”
or “idiopathic”
tirtharaja76@gmail.com
2
Classification
 So an specific cut off point is difficult
 WHO (1972) –systolic above 160/diastolic (phase V) more than 95
Currently
 Optimal-<120mmHg and<80 mmHg
tirtharaja76@gmail.com
3
Category Blood Pressure, mm Hg
Normal SBP 90-119 and DBP 60-79
Prehypertension SBP 120-139 or DBP 80-89
Stage 1 HTN SBP 140-159 or DBP 90-99
Stage 2 HTN SBP ≥160 or DBP ≥100
DBP = diastolic blood pressure; SBP = systolic blood pressure
Measurement of BP
Accuracy is essential
Reliability is questionable as wide variability in
individual.
Source of ERROR-
1. Observer error e.g. hearing acuity, interpretation of
Karotkow sound
2 Instrumental error eg loose cuff,leaking valve etc
3 subject error eg position , external stimuli-fear ,anxiety,
physical environment
tirtharaja76@gmail.com
4
WHO recommendation
Measurement of BP in individual
Uniform policy in all clinics &institutions to use rt or left
arm
Recording in sitting position than supine
Systolic at which sound first heard
Diastolic -sound muffled disappear
Measured at least 3 times over a period of 3 minutes &
lowest reading is taken
For comparability data should be taken every where in
uniform way
tirtharaja76@gmail.com
5
Measurement in community
Incidence has limitation due to
 individual variation,
 ambiguity of normal BP
 insidious nature of condition
Prevalence-
 Developed countries-25% in adult population
 Developing countries-10 to 20% in adult population
 High altitude & places belonging to primitive culture-very low
tirtharaja76@gmail.com
6
Measurement in community(cont)
The prevalence of hypertension was
44.9 percent (47.75% in male and 42.73% in females).
The higher proportion of hypertensive cases were
in age > 65 years (55.49%) than in the age group < 65 years
(36.32%).
The prevalence of hypertension was seen positively associated
with
non vegetarian eating habits, alcohol consumption, and >
25 Body max index. (Prevalence and Associated Risk Factors of Hypertension Among People Aged 50 years and more in
Banepa Municipality, Nepal)
tirtharaja76@gmail.com
7
Mortality
In western world: deaths due to coronary heart
disease
In eastern parts of the world: stroke deaths more
common
Decline in mortality in last 2 decades
Fall is equal in both sexes
Fall attributed to, use of effective drugs, modern
diagnosis &treatment
tirtharaja76@gmail.com
8
Risk Factors in HTN
Modifiable risk factors
• Stress
• Smoking and HTN
• Alcohol and BP
• Obesity
• Diabeties Mellitus
• Salt and HTN
• Occupation
• Personality
• Coffee and tea
Non modifiable
risk factors
• Family History
• Ethnicity and Race
• Age
• Sex/ Gender
tirtharaja76@gmail.com
9
Cardiovascular Risk Factors
Hypertension
Cigarette smoking
Obesity (BMI>30)
Inactivity
Dyslipidemia
Diabetes Mellitus
Age
 >55 for men
 >65 for women
Microalbuminuria
 Or GFR <60mL/min
FH of Premature CVD
 Men <55
 Women <65
tirtharaja76@gmail.com
10
Birth Weight
Birth weight is also associated with the development
of hypertension in later life.
The lower the birth weight the higher the likelihood
of developing hypertension and heart disease
Clearly in-utero factors affect health at a later stage.
tirtharaja76@gmail.com
11
Blood pressure is a continuous variable which
fluctuates widely during the day
 physical stress
 mental stress
The definition of hypertension has been arbitrarily
set as:
That blood pressure above which the benefits
of treatment outweigh the risks in terms of
morbidity and mortality
tirtharaja76@gmail.com
12
Hypertension
Hypertension is not a disease
It is an arbitrarily defined disorder to which
both environmental and genetic factors
contribute
tirtharaja76@gmail.com
13
tirtharaja76@gmail.com
14
Causes for Secondary Hypertension
Renal disease
 20% of resistant hypertensive patients
 chronic pyelonephritis
 renal artery stenosis
 polycystic kidneys
Drug Induced
 NSAIDs
 Oral contraceptive
 Corticosteroids
tirtharaja76@gmail.com
15
Drug Induced Causes of HTN
Illicit Drugs
 Cocaine, amphetamines
Oral Contraceptives
Adrenal Steroids
 Prednisone
Licorice (in some chewing tobacco)
Decongestants (sympathomimetics)
Non-adherence, inadequate doses, inappropriate
combinations
Non steroidal Anti-inflammatory drugs
tirtharaja76@gmail.com
16
Diagnostic features of the HTN
No symptoms in 90 of the cases even when BP is
very high i.e. > 160/100 mm of Hg
Headaches , dizziness
BP > 140/90 mm of Hg measured in the different
time and situations
tirtharaja76@gmail.com
17
Treatment and management
A/C STP drug T. Amlodipine 5mg OD if BP doesnot go in
the 140/90 mm of Hg add Hydrochlorothiazide 25 mg OD
in morning.
If not controlled add T. Atenolol 50mg OD(if there is no CI
for Beta blocker)
Lifestyle modification and dietary modification
Cessation of the smoking and alcohol intake
Regular physical exercise
Control salt, fat, obesity
Follow healthy life style
Continuation of the medication untill medical consultation
tirtharaja76@gmail.com
18
Malignant Hypertension:
 May complicate any type of HTN.
 Necrotizing arteriolitis.
 Intravascular thrombosis.
 Rapidly progressive end organ damage.
 Renal failure
 Hypertensive encephalopathy.
 Left ventricular failure.
tirtharaja76@gmail.com
19
Consequences of Hypertension:
 Blood Vessels
 Atherosclerosis and its complications aneurism,
Dissection, Rupture, necrosis. Arteriolosclerosis,
 Heart
 Hypertensive cardiomyopathy, IHD, MI.
 Kidney
 Benign/Malignant nephrosclerosis. Infarction
 Eyes:
 Hypertensive retinopathy
 Brain:
 Haemorrhage, infarction,
 splinter & Lacunar hemorrhages
tirtharaja76@gmail.com
20
Left ventricular Hypertrophy:
Left Ventricular HypertrophyLeft Ventricular Hypertrophy
tirtharaja76@gmail.com
21
Cerebral Infarction (Stroke) :
HaemorrhagicHaemorrhagic
NecrosisNecrosis
tirtharaja76@gmail.com
22
Cerebral Infarction:
tirtharaja76@gmail.com
23
Subarachnoid Haemorrhage:
tirtharaja76@gmail.com
24
Renal Artery stenosis - Atrophy
Leathery Granularity
Benign Nephrosclerosis
tirtharaja76@gmail.com
25
Normal Retina - Fundoscopy
tirtharaja76@gmail.com
26
Hypertensive Retinopathy:
 Grade I – Thickening of
arterioles.
 Grade II – Focal Arteriolar
spasms. Vein constriction.
 Grade III – Hemorrhages
(Flame shape), dot-blot and
Cotton wool and hard waxy
exudates.
 Grade IV - Papilloedema
tirtharaja76@gmail.com
27
TREATMENT MODALITY IN GENERAL
Principle:- “lower the pressure, the better”
Goal:- to have maximally tolerated reduction in
blood pressure
tirtharaja76@gmail.com
28
MILD HYPERTENSION
Monodrug therapy
Drug of choice:
1. Thiazide diuretic
eg. Hydrochlorthiazide
2. β1 blocker
eg. Propanolol
If monotherapy doesn’t work other drug can be added
eg.Thiazide+ β1blocker
tirtharaja76@gmail.com
29
ABCD treatment in HTN
tirtharaja76@gmail.com
30
A ACE inhibitor Enalapril / Captopril
B Beta blocker Atenolol / propanolol
C Calcium channel blocker Amlodipine/ Morphe
depine
D Diuretics Fursemide
Special cases
1.PREGNANCY
Toxemia of pregnancy
Drug of choice: β1blocker
vasodilator
Ca++
channel blocker
-Contraindicated drugs are
Diuretics,Resperine,Na nitroprusside,
Non selective β -blocker
tirtharaja76@gmail.com
31
2.Heart Disease
All A,B,C and D are useful
β1 blocker are contraindicated in left ventricular
failure & bradycardia
3.Diabetic
ACE inhibitor (Captopril)
low dose thiazide, beta 1 blocker and Ca channel
blocker for long term therapy
contraindicated diuretics
tirtharaja76@gmail.com
32
4. Hypertensive Emergency
Life threatening, DP > 130 mmHg
Sodium nitroprusside (vasodilator)
Diazoxide (arterial dilator )
Labetolol ( non selective adrenergic blocker )
5. Hypertensive urgency
Nifedipine (Sub lingual)
Clonidine (oral or IM every 1-2 hrs)
Captopril ( oral)
Hydralazine (IM or IV slowly)
tirtharaja76@gmail.com
33
AND CONTROL OF
HTN
PREVENTION
tirtharaja76@gmail.com
34
Lifestyle Modification: 1
Weight Reduction
 Maintain normal body weight
 BMI: 18.5 – 24.9
 BP reduction: 5-20 mmHg/10 kg loss
DASH Eating Plan
 Dietary Approaches to Stop Hypertension
 Fruits, Vegetables, Low-fat dairy
 Reduce saturated and total fat
 8-14 mmHg BP reduction
tirtharaja76@gmail.com
35
Lifestyle Modification: 2
Dietary Sodium Reduction
 2.4 grams Sodium or 6 grams Sodium Chloride
 2-8 mmHg BP reduction
Physical Activity
 Regular aerobic physical activity
 Brisk walking, treadmill, exercise bike, bicycling, swimming (30 min.
a day, most days of the week)
 4-9 mmHg BP reduction
tirtharaja76@gmail.com
36
Lifestyle Modification: 3
Moderation of alcohol consumption
 No more than 2 drinks per day in most men
 No more than 1 drink per day in women and lighter weight
individuals
 One drink equals:
 ½ ounce liquor or
 12 oz. Beer or
 5 oz. Wine or
 1 ½ oz. 80 proof whisky
tirtharaja76@gmail.com
37
tirtharaja76@gmail.com 38
Be serious for
HTN pts in
following
Patient History: I
Duration and prior Rx
Pharmaceutical profile
Family history
Symptoms of secondary causes
Target organ damage
Presence of other risk factors
tirtharaja76@gmail.com
39
Patient History: II
Concomitant Diseases
Dietary History
Sexual Function
Features of Sleep Apnea
Ability to modify life-style
tirtharaja76@gmail.com
40
Physical Examination: I
Accurate measure of BP, BMI
Fundoscopy
Carotid and thyroid abnormalities
Heart sounds, rhythm, size
Rales, rhonchi on lung exam
tirtharaja76@gmail.com
41
THANK YOU FOR YOUR
GREAT
CONCENTRATION
tirtharaja76@gmail.com
42

More Related Content

What's hot

Primary PCI
Primary PCIPrimary PCI
Primary PCI
PERKI Pekanbaru
 
Hypertesnion Update 2020 Jan
Hypertesnion Update 2020 JanHypertesnion Update 2020 Jan
Hypertesnion Update 2020 Jan
Navas Shareef
 
Ramadan and cvd
Ramadan and cvdRamadan and cvd
Ramadan and cvd
FarragBahbah
 
BMV,PTMC,BALLOON MITRAL VALVOTOMY, BAL, VIRBHAN BALAI, DR VIRBHAN
BMV,PTMC,BALLOON MITRAL VALVOTOMY, BAL, VIRBHAN BALAI, DR VIRBHANBMV,PTMC,BALLOON MITRAL VALVOTOMY, BAL, VIRBHAN BALAI, DR VIRBHAN
BMV,PTMC,BALLOON MITRAL VALVOTOMY, BAL, VIRBHAN BALAI, DR VIRBHAN
Dr Virbhan Balai
 
Atrial arrhythmia
Atrial arrhythmiaAtrial arrhythmia
Atrial arrhythmia
MEEQAT HOSPITAL
 
Shift Trial on HF
Shift Trial on HFShift Trial on HF
Shift Trial on HF
DhimanBanik1
 
Basic of ECG by Harison
Basic of ECG by HarisonBasic of ECG by Harison
Basic of ECG by Harison
harisongill
 
Update in hypertension management
Update in hypertension managementUpdate in hypertension management
Update in hypertension management
Tarek Khalil
 
Sinus tachycardia
Sinus tachycardiaSinus tachycardia
Sinus tachycardia
Ann Bentley
 
Epidemiology , diagnosis and treatment of Hypertension
Epidemiology , diagnosis and treatment of Hypertension Epidemiology , diagnosis and treatment of Hypertension
Epidemiology , diagnosis and treatment of Hypertension
Toufiqur Rahman
 
Prami trial
Prami trialPrami trial
Prami trial
Praveen Nagula
 
Atrial tachycardia
Atrial tachycardiaAtrial tachycardia
Atrial tachycardia
Taiwan Heart Rhythm Society
 
Narrow qrs tachy i.tammi raju
Narrow qrs tachy i.tammi rajuNarrow qrs tachy i.tammi raju
Narrow qrs tachy i.tammi raju
Tammiraju Iragavarapu
 
Primary Percutaneus coronary intervention
Primary Percutaneus coronary interventionPrimary Percutaneus coronary intervention
Primary Percutaneus coronary intervention
Ramachandra Barik
 
Tachyarrhythmias
TachyarrhythmiasTachyarrhythmias
Tachyarrhythmias
Kurian Joseph
 
Management of hypertension
Management of hypertension   Management of hypertension
Management of hypertension
Rivindu Wickramanayake
 
HYPOPLASTIC LEFT HEART SYNDROME & NORWOOD PROCEDURE- A REVIEW
HYPOPLASTIC LEFT HEART SYNDROME & NORWOOD PROCEDURE- A REVIEWHYPOPLASTIC LEFT HEART SYNDROME & NORWOOD PROCEDURE- A REVIEW
HYPOPLASTIC LEFT HEART SYNDROME & NORWOOD PROCEDURE- A REVIEW
Dr. Murtaza Kamal MD,DNB,DrNB Ped Cardiology
 
Anticoagulation during mechanical support by Dr Sara Allen
Anticoagulation during mechanical support by Dr Sara AllenAnticoagulation during mechanical support by Dr Sara Allen
Anticoagulation during mechanical support by Dr Sara Allen
CICM 2019 Annual Scientific Meeting
 
ATRIAL ARRHYTHMIAS
ATRIAL ARRHYTHMIASATRIAL ARRHYTHMIAS
ATRIAL ARRHYTHMIAS
BabieChong Haokip
 
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment optionsSGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
ahvc0858
 

What's hot (20)

Primary PCI
Primary PCIPrimary PCI
Primary PCI
 
Hypertesnion Update 2020 Jan
Hypertesnion Update 2020 JanHypertesnion Update 2020 Jan
Hypertesnion Update 2020 Jan
 
Ramadan and cvd
Ramadan and cvdRamadan and cvd
Ramadan and cvd
 
BMV,PTMC,BALLOON MITRAL VALVOTOMY, BAL, VIRBHAN BALAI, DR VIRBHAN
BMV,PTMC,BALLOON MITRAL VALVOTOMY, BAL, VIRBHAN BALAI, DR VIRBHANBMV,PTMC,BALLOON MITRAL VALVOTOMY, BAL, VIRBHAN BALAI, DR VIRBHAN
BMV,PTMC,BALLOON MITRAL VALVOTOMY, BAL, VIRBHAN BALAI, DR VIRBHAN
 
Atrial arrhythmia
Atrial arrhythmiaAtrial arrhythmia
Atrial arrhythmia
 
Shift Trial on HF
Shift Trial on HFShift Trial on HF
Shift Trial on HF
 
Basic of ECG by Harison
Basic of ECG by HarisonBasic of ECG by Harison
Basic of ECG by Harison
 
Update in hypertension management
Update in hypertension managementUpdate in hypertension management
Update in hypertension management
 
Sinus tachycardia
Sinus tachycardiaSinus tachycardia
Sinus tachycardia
 
Epidemiology , diagnosis and treatment of Hypertension
Epidemiology , diagnosis and treatment of Hypertension Epidemiology , diagnosis and treatment of Hypertension
Epidemiology , diagnosis and treatment of Hypertension
 
Prami trial
Prami trialPrami trial
Prami trial
 
Atrial tachycardia
Atrial tachycardiaAtrial tachycardia
Atrial tachycardia
 
Narrow qrs tachy i.tammi raju
Narrow qrs tachy i.tammi rajuNarrow qrs tachy i.tammi raju
Narrow qrs tachy i.tammi raju
 
Primary Percutaneus coronary intervention
Primary Percutaneus coronary interventionPrimary Percutaneus coronary intervention
Primary Percutaneus coronary intervention
 
Tachyarrhythmias
TachyarrhythmiasTachyarrhythmias
Tachyarrhythmias
 
Management of hypertension
Management of hypertension   Management of hypertension
Management of hypertension
 
HYPOPLASTIC LEFT HEART SYNDROME & NORWOOD PROCEDURE- A REVIEW
HYPOPLASTIC LEFT HEART SYNDROME & NORWOOD PROCEDURE- A REVIEWHYPOPLASTIC LEFT HEART SYNDROME & NORWOOD PROCEDURE- A REVIEW
HYPOPLASTIC LEFT HEART SYNDROME & NORWOOD PROCEDURE- A REVIEW
 
Anticoagulation during mechanical support by Dr Sara Allen
Anticoagulation during mechanical support by Dr Sara AllenAnticoagulation during mechanical support by Dr Sara Allen
Anticoagulation during mechanical support by Dr Sara Allen
 
ATRIAL ARRHYTHMIAS
ATRIAL ARRHYTHMIASATRIAL ARRHYTHMIAS
ATRIAL ARRHYTHMIAS
 
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment optionsSGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
SGLT2 inhibitors in Heart failure: A prized addition to HF treatment options
 

Similar to Hypertension on standard treatment protocol of Nepal

Bugando Hypertension.pptx
Bugando Hypertension.pptxBugando Hypertension.pptx
Bugando Hypertension.pptx
Mkindi Mkindi
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
PaNkajGupTa467037
 
Diagnosis and management of Hypertension.ppt
Diagnosis and management of Hypertension.pptDiagnosis and management of Hypertension.ppt
Diagnosis and management of Hypertension.ppt
KashinathBolakotagi
 
hypertensionfinal-230421053519-5d60216a.pdf
hypertensionfinal-230421053519-5d60216a.pdfhypertensionfinal-230421053519-5d60216a.pdf
hypertensionfinal-230421053519-5d60216a.pdf
RezaOskui1
 
Treatment of Hypertension Treatment of Hypertension
Treatment of Hypertension 	 Treatment of HypertensionTreatment of Hypertension 	 Treatment of Hypertension
Treatment of Hypertension Treatment of Hypertension
MedicineAndHealthCancer
 
Webinar on Hypertension- The Silent Killer : Hinduja Hospital
Webinar on Hypertension- The Silent Killer : Hinduja HospitalWebinar on Hypertension- The Silent Killer : Hinduja Hospital
Webinar on Hypertension- The Silent Killer : Hinduja Hospital
Hinduja Hospital
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
Sudha Sudha
 
Hypertension diagnosis and management
Hypertension diagnosis and managementHypertension diagnosis and management
Hypertension diagnosis and management
shashank agrawal
 
Hypertension Management
Hypertension ManagementHypertension Management
Hypertension Management
Marjanul Alam
 
Hypertension
HypertensionHypertension
Hypertension
ashafernandes4
 
hypertension final (4).ppt
hypertension final (4).ppthypertension final (4).ppt
hypertension final (4).ppt
GovernmentUnaniHospi
 
hypertension final (4).ppt
hypertension final (4).ppthypertension final (4).ppt
hypertension final (4).ppt
GovernmentUnaniHospi
 
htn-online-1233841166580172-3.pptx
htn-online-1233841166580172-3.pptxhtn-online-1233841166580172-3.pptx
htn-online-1233841166580172-3.pptx
AreebWaheed
 
Hypertension
HypertensionHypertension
Hypertension
dhavalshah4424
 
Hypertension
HypertensionHypertension
Hypertension
TELIAZERTharmaraj
 
hypertension ppt on high bp By Dr kartik
hypertension ppt on high bp By Dr kartikhypertension ppt on high bp By Dr kartik
hypertension ppt on high bp By Dr kartik
KartikChoudhary496548
 
HYPERTENSION PPT.pptx detailed explanation
HYPERTENSION PPT.pptx detailed explanationHYPERTENSION PPT.pptx detailed explanation
HYPERTENSION PPT.pptx detailed explanation
jinsigeorge
 
5 hypertension final.ppt¹1111111111111111
5 hypertension final.ppt¹11111111111111115 hypertension final.ppt¹1111111111111111
5 hypertension final.ppt¹1111111111111111
marrahmohamed33
 
BLOOD PRESSURE- WORLD HEALTH DAY 2013
BLOOD PRESSURE- WORLD HEALTH DAY 2013        BLOOD PRESSURE- WORLD HEALTH DAY 2013
BLOOD PRESSURE- WORLD HEALTH DAY 2013
Naveen Kumar
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
chiapas52
 

Similar to Hypertension on standard treatment protocol of Nepal (20)

Bugando Hypertension.pptx
Bugando Hypertension.pptxBugando Hypertension.pptx
Bugando Hypertension.pptx
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
 
Diagnosis and management of Hypertension.ppt
Diagnosis and management of Hypertension.pptDiagnosis and management of Hypertension.ppt
Diagnosis and management of Hypertension.ppt
 
hypertensionfinal-230421053519-5d60216a.pdf
hypertensionfinal-230421053519-5d60216a.pdfhypertensionfinal-230421053519-5d60216a.pdf
hypertensionfinal-230421053519-5d60216a.pdf
 
Treatment of Hypertension Treatment of Hypertension
Treatment of Hypertension 	 Treatment of HypertensionTreatment of Hypertension 	 Treatment of Hypertension
Treatment of Hypertension Treatment of Hypertension
 
Webinar on Hypertension- The Silent Killer : Hinduja Hospital
Webinar on Hypertension- The Silent Killer : Hinduja HospitalWebinar on Hypertension- The Silent Killer : Hinduja Hospital
Webinar on Hypertension- The Silent Killer : Hinduja Hospital
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
 
Hypertension diagnosis and management
Hypertension diagnosis and managementHypertension diagnosis and management
Hypertension diagnosis and management
 
Hypertension Management
Hypertension ManagementHypertension Management
Hypertension Management
 
Hypertension
HypertensionHypertension
Hypertension
 
hypertension final (4).ppt
hypertension final (4).ppthypertension final (4).ppt
hypertension final (4).ppt
 
hypertension final (4).ppt
hypertension final (4).ppthypertension final (4).ppt
hypertension final (4).ppt
 
htn-online-1233841166580172-3.pptx
htn-online-1233841166580172-3.pptxhtn-online-1233841166580172-3.pptx
htn-online-1233841166580172-3.pptx
 
Hypertension
HypertensionHypertension
Hypertension
 
Hypertension
HypertensionHypertension
Hypertension
 
hypertension ppt on high bp By Dr kartik
hypertension ppt on high bp By Dr kartikhypertension ppt on high bp By Dr kartik
hypertension ppt on high bp By Dr kartik
 
HYPERTENSION PPT.pptx detailed explanation
HYPERTENSION PPT.pptx detailed explanationHYPERTENSION PPT.pptx detailed explanation
HYPERTENSION PPT.pptx detailed explanation
 
5 hypertension final.ppt¹1111111111111111
5 hypertension final.ppt¹11111111111111115 hypertension final.ppt¹1111111111111111
5 hypertension final.ppt¹1111111111111111
 
BLOOD PRESSURE- WORLD HEALTH DAY 2013
BLOOD PRESSURE- WORLD HEALTH DAY 2013        BLOOD PRESSURE- WORLD HEALTH DAY 2013
BLOOD PRESSURE- WORLD HEALTH DAY 2013
 
hypertension final.ppt
hypertension final.ppthypertension final.ppt
hypertension final.ppt
 

More from Public Health Concern Nepal

लोकसेवा आयोग तथा कुनै पनि प्रतिस्पर्धात्मक परीक्षाको तयारी.pptx
लोकसेवा आयोग तथा कुनै पनि प्रतिस्पर्धात्मक परीक्षाको तयारी.pptxलोकसेवा आयोग तथा कुनै पनि प्रतिस्पर्धात्मक परीक्षाको तयारी.pptx
लोकसेवा आयोग तथा कुनै पनि प्रतिस्पर्धात्मक परीक्षाको तयारी.pptx
Public Health Concern Nepal
 
Non-Communicable Diseases (NCD) and Global Health 2024
Non-Communicable Diseases (NCD) and Global Health 2024Non-Communicable Diseases (NCD) and Global Health 2024
Non-Communicable Diseases (NCD) and Global Health 2024
Public Health Concern Nepal
 
Session 2_ Introduction of NIP .pdf
Session 2_ Introduction of NIP .pdfSession 2_ Introduction of NIP .pdf
Session 2_ Introduction of NIP .pdf
Public Health Concern Nepal
 
Introduction of eLMIS_ LMIS Data entr.pptx
Introduction of eLMIS_ LMIS Data entr.pptxIntroduction of eLMIS_ LMIS Data entr.pptx
Introduction of eLMIS_ LMIS Data entr.pptx
Public Health Concern Nepal
 
Family-Planning-Programme/Day_PPT..pdf
Family-Planning-Programme/Day_PPT..pdfFamily-Planning-Programme/Day_PPT..pdf
Family-Planning-Programme/Day_PPT..pdf
Public Health Concern Nepal
 
Vaccines &amp; cold chain
Vaccines &amp; cold chainVaccines &amp; cold chain
Vaccines &amp; cold chain
Public Health Concern Nepal
 

More from Public Health Concern Nepal (6)

लोकसेवा आयोग तथा कुनै पनि प्रतिस्पर्धात्मक परीक्षाको तयारी.pptx
लोकसेवा आयोग तथा कुनै पनि प्रतिस्पर्धात्मक परीक्षाको तयारी.pptxलोकसेवा आयोग तथा कुनै पनि प्रतिस्पर्धात्मक परीक्षाको तयारी.pptx
लोकसेवा आयोग तथा कुनै पनि प्रतिस्पर्धात्मक परीक्षाको तयारी.pptx
 
Non-Communicable Diseases (NCD) and Global Health 2024
Non-Communicable Diseases (NCD) and Global Health 2024Non-Communicable Diseases (NCD) and Global Health 2024
Non-Communicable Diseases (NCD) and Global Health 2024
 
Session 2_ Introduction of NIP .pdf
Session 2_ Introduction of NIP .pdfSession 2_ Introduction of NIP .pdf
Session 2_ Introduction of NIP .pdf
 
Introduction of eLMIS_ LMIS Data entr.pptx
Introduction of eLMIS_ LMIS Data entr.pptxIntroduction of eLMIS_ LMIS Data entr.pptx
Introduction of eLMIS_ LMIS Data entr.pptx
 
Family-Planning-Programme/Day_PPT..pdf
Family-Planning-Programme/Day_PPT..pdfFamily-Planning-Programme/Day_PPT..pdf
Family-Planning-Programme/Day_PPT..pdf
 
Vaccines &amp; cold chain
Vaccines &amp; cold chainVaccines &amp; cold chain
Vaccines &amp; cold chain
 

Recently uploaded

Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga
 
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticalsacne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
MuskanShingari
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Kunj Vihari
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
Gokuldas Hospital
 
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
PVI, PeerView Institute for Medical Education
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
MuhammadMuneer49
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
ShraddhaTamshettiwar
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Rahul Sen
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
KerlynIgnacio
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
Dr. Sumit KUMAR
 
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl MumbaiCall Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Mobile Problem
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
SIVAVINAYAKPK
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
MRI for Surgeons introduction and basics
MRI for Surgeons  introduction and basicsMRI for Surgeons  introduction and basics
MRI for Surgeons introduction and basics
rohitsharma19711
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
DrGirishJHoogar
 

Recently uploaded (20)

Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
 
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticalsacne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
acne vulgaris -Mpharm (2nd semester) Cosmetics and cosmeceuticals
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
 
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
 
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl MumbaiCall Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
MRI for Surgeons introduction and basics
MRI for Surgeons  introduction and basicsMRI for Surgeons  introduction and basics
MRI for Surgeons introduction and basics
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
 

Hypertension on standard treatment protocol of Nepal

  • 1. PREPARED BY TIRTHARAJ ACHARYA H.A NOW THUMKI HEALTH POST tirtharaja76@gmail.com 1 HYPERTENSION
  • 2. Definition of Hypertension Dorland’s Medical Dictionary  “Persistently high arterial blood pressure” Diastolic Hypertension  Elevated diastolic blood pressure with a normal systolic pressure Essential Hypertension  Elevated blood pressure “having no obvious external cause,” or “idiopathic” tirtharaja76@gmail.com 2
  • 3. Classification  So an specific cut off point is difficult  WHO (1972) –systolic above 160/diastolic (phase V) more than 95 Currently  Optimal-<120mmHg and<80 mmHg tirtharaja76@gmail.com 3 Category Blood Pressure, mm Hg Normal SBP 90-119 and DBP 60-79 Prehypertension SBP 120-139 or DBP 80-89 Stage 1 HTN SBP 140-159 or DBP 90-99 Stage 2 HTN SBP ≥160 or DBP ≥100 DBP = diastolic blood pressure; SBP = systolic blood pressure
  • 4. Measurement of BP Accuracy is essential Reliability is questionable as wide variability in individual. Source of ERROR- 1. Observer error e.g. hearing acuity, interpretation of Karotkow sound 2 Instrumental error eg loose cuff,leaking valve etc 3 subject error eg position , external stimuli-fear ,anxiety, physical environment tirtharaja76@gmail.com 4
  • 5. WHO recommendation Measurement of BP in individual Uniform policy in all clinics &institutions to use rt or left arm Recording in sitting position than supine Systolic at which sound first heard Diastolic -sound muffled disappear Measured at least 3 times over a period of 3 minutes & lowest reading is taken For comparability data should be taken every where in uniform way tirtharaja76@gmail.com 5
  • 6. Measurement in community Incidence has limitation due to  individual variation,  ambiguity of normal BP  insidious nature of condition Prevalence-  Developed countries-25% in adult population  Developing countries-10 to 20% in adult population  High altitude & places belonging to primitive culture-very low tirtharaja76@gmail.com 6
  • 7. Measurement in community(cont) The prevalence of hypertension was 44.9 percent (47.75% in male and 42.73% in females). The higher proportion of hypertensive cases were in age > 65 years (55.49%) than in the age group < 65 years (36.32%). The prevalence of hypertension was seen positively associated with non vegetarian eating habits, alcohol consumption, and > 25 Body max index. (Prevalence and Associated Risk Factors of Hypertension Among People Aged 50 years and more in Banepa Municipality, Nepal) tirtharaja76@gmail.com 7
  • 8. Mortality In western world: deaths due to coronary heart disease In eastern parts of the world: stroke deaths more common Decline in mortality in last 2 decades Fall is equal in both sexes Fall attributed to, use of effective drugs, modern diagnosis &treatment tirtharaja76@gmail.com 8
  • 9. Risk Factors in HTN Modifiable risk factors • Stress • Smoking and HTN • Alcohol and BP • Obesity • Diabeties Mellitus • Salt and HTN • Occupation • Personality • Coffee and tea Non modifiable risk factors • Family History • Ethnicity and Race • Age • Sex/ Gender tirtharaja76@gmail.com 9
  • 10. Cardiovascular Risk Factors Hypertension Cigarette smoking Obesity (BMI>30) Inactivity Dyslipidemia Diabetes Mellitus Age  >55 for men  >65 for women Microalbuminuria  Or GFR <60mL/min FH of Premature CVD  Men <55  Women <65 tirtharaja76@gmail.com 10
  • 11. Birth Weight Birth weight is also associated with the development of hypertension in later life. The lower the birth weight the higher the likelihood of developing hypertension and heart disease Clearly in-utero factors affect health at a later stage. tirtharaja76@gmail.com 11
  • 12. Blood pressure is a continuous variable which fluctuates widely during the day  physical stress  mental stress The definition of hypertension has been arbitrarily set as: That blood pressure above which the benefits of treatment outweigh the risks in terms of morbidity and mortality tirtharaja76@gmail.com 12
  • 13. Hypertension Hypertension is not a disease It is an arbitrarily defined disorder to which both environmental and genetic factors contribute tirtharaja76@gmail.com 13
  • 15. Causes for Secondary Hypertension Renal disease  20% of resistant hypertensive patients  chronic pyelonephritis  renal artery stenosis  polycystic kidneys Drug Induced  NSAIDs  Oral contraceptive  Corticosteroids tirtharaja76@gmail.com 15
  • 16. Drug Induced Causes of HTN Illicit Drugs  Cocaine, amphetamines Oral Contraceptives Adrenal Steroids  Prednisone Licorice (in some chewing tobacco) Decongestants (sympathomimetics) Non-adherence, inadequate doses, inappropriate combinations Non steroidal Anti-inflammatory drugs tirtharaja76@gmail.com 16
  • 17. Diagnostic features of the HTN No symptoms in 90 of the cases even when BP is very high i.e. > 160/100 mm of Hg Headaches , dizziness BP > 140/90 mm of Hg measured in the different time and situations tirtharaja76@gmail.com 17
  • 18. Treatment and management A/C STP drug T. Amlodipine 5mg OD if BP doesnot go in the 140/90 mm of Hg add Hydrochlorothiazide 25 mg OD in morning. If not controlled add T. Atenolol 50mg OD(if there is no CI for Beta blocker) Lifestyle modification and dietary modification Cessation of the smoking and alcohol intake Regular physical exercise Control salt, fat, obesity Follow healthy life style Continuation of the medication untill medical consultation tirtharaja76@gmail.com 18
  • 19. Malignant Hypertension:  May complicate any type of HTN.  Necrotizing arteriolitis.  Intravascular thrombosis.  Rapidly progressive end organ damage.  Renal failure  Hypertensive encephalopathy.  Left ventricular failure. tirtharaja76@gmail.com 19
  • 20. Consequences of Hypertension:  Blood Vessels  Atherosclerosis and its complications aneurism, Dissection, Rupture, necrosis. Arteriolosclerosis,  Heart  Hypertensive cardiomyopathy, IHD, MI.  Kidney  Benign/Malignant nephrosclerosis. Infarction  Eyes:  Hypertensive retinopathy  Brain:  Haemorrhage, infarction,  splinter & Lacunar hemorrhages tirtharaja76@gmail.com 20
  • 21. Left ventricular Hypertrophy: Left Ventricular HypertrophyLeft Ventricular Hypertrophy tirtharaja76@gmail.com 21
  • 22. Cerebral Infarction (Stroke) : HaemorrhagicHaemorrhagic NecrosisNecrosis tirtharaja76@gmail.com 22
  • 25. Renal Artery stenosis - Atrophy Leathery Granularity Benign Nephrosclerosis tirtharaja76@gmail.com 25
  • 26. Normal Retina - Fundoscopy tirtharaja76@gmail.com 26
  • 27. Hypertensive Retinopathy:  Grade I – Thickening of arterioles.  Grade II – Focal Arteriolar spasms. Vein constriction.  Grade III – Hemorrhages (Flame shape), dot-blot and Cotton wool and hard waxy exudates.  Grade IV - Papilloedema tirtharaja76@gmail.com 27
  • 28. TREATMENT MODALITY IN GENERAL Principle:- “lower the pressure, the better” Goal:- to have maximally tolerated reduction in blood pressure tirtharaja76@gmail.com 28
  • 29. MILD HYPERTENSION Monodrug therapy Drug of choice: 1. Thiazide diuretic eg. Hydrochlorthiazide 2. β1 blocker eg. Propanolol If monotherapy doesn’t work other drug can be added eg.Thiazide+ β1blocker tirtharaja76@gmail.com 29
  • 30. ABCD treatment in HTN tirtharaja76@gmail.com 30 A ACE inhibitor Enalapril / Captopril B Beta blocker Atenolol / propanolol C Calcium channel blocker Amlodipine/ Morphe depine D Diuretics Fursemide
  • 31. Special cases 1.PREGNANCY Toxemia of pregnancy Drug of choice: β1blocker vasodilator Ca++ channel blocker -Contraindicated drugs are Diuretics,Resperine,Na nitroprusside, Non selective β -blocker tirtharaja76@gmail.com 31
  • 32. 2.Heart Disease All A,B,C and D are useful β1 blocker are contraindicated in left ventricular failure & bradycardia 3.Diabetic ACE inhibitor (Captopril) low dose thiazide, beta 1 blocker and Ca channel blocker for long term therapy contraindicated diuretics tirtharaja76@gmail.com 32
  • 33. 4. Hypertensive Emergency Life threatening, DP > 130 mmHg Sodium nitroprusside (vasodilator) Diazoxide (arterial dilator ) Labetolol ( non selective adrenergic blocker ) 5. Hypertensive urgency Nifedipine (Sub lingual) Clonidine (oral or IM every 1-2 hrs) Captopril ( oral) Hydralazine (IM or IV slowly) tirtharaja76@gmail.com 33
  • 35. Lifestyle Modification: 1 Weight Reduction  Maintain normal body weight  BMI: 18.5 – 24.9  BP reduction: 5-20 mmHg/10 kg loss DASH Eating Plan  Dietary Approaches to Stop Hypertension  Fruits, Vegetables, Low-fat dairy  Reduce saturated and total fat  8-14 mmHg BP reduction tirtharaja76@gmail.com 35
  • 36. Lifestyle Modification: 2 Dietary Sodium Reduction  2.4 grams Sodium or 6 grams Sodium Chloride  2-8 mmHg BP reduction Physical Activity  Regular aerobic physical activity  Brisk walking, treadmill, exercise bike, bicycling, swimming (30 min. a day, most days of the week)  4-9 mmHg BP reduction tirtharaja76@gmail.com 36
  • 37. Lifestyle Modification: 3 Moderation of alcohol consumption  No more than 2 drinks per day in most men  No more than 1 drink per day in women and lighter weight individuals  One drink equals:  ½ ounce liquor or  12 oz. Beer or  5 oz. Wine or  1 ½ oz. 80 proof whisky tirtharaja76@gmail.com 37
  • 38. tirtharaja76@gmail.com 38 Be serious for HTN pts in following
  • 39. Patient History: I Duration and prior Rx Pharmaceutical profile Family history Symptoms of secondary causes Target organ damage Presence of other risk factors tirtharaja76@gmail.com 39
  • 40. Patient History: II Concomitant Diseases Dietary History Sexual Function Features of Sleep Apnea Ability to modify life-style tirtharaja76@gmail.com 40
  • 41. Physical Examination: I Accurate measure of BP, BMI Fundoscopy Carotid and thyroid abnormalities Heart sounds, rhythm, size Rales, rhonchi on lung exam tirtharaja76@gmail.com 41
  • 42. THANK YOU FOR YOUR GREAT CONCENTRATION tirtharaja76@gmail.com 42